Finance

Lists
NX1:ASX
Nexalis Therapeutics Ltd
A$ 0.010
0.00%
(0.00) 1D
9-р сарын 2, 14:38:30 (GMT+10)  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NX1...
Mkt. cap
2.28 сая
Avg. vol.
36.17 мян
Volume
0.00
52-wk high
A$ 0.03
52-wk low
A$ 0.01
EPS
-A$ 0.01
Shares outstanding
253.04 сая
Mkt. cap
2.28 сая
Avg. vol.
36.17 мян
Volume
0.00
52-wk high
A$ 0.03
52-wk low
A$ 0.01
EPS
-A$ 0.01
Shares outstanding
253.04 сая
About Nexalis Therapeutics Ltd
CEO-
Employees-
Founded2016
Headquarters-
SectorPharmaceutical industry
Websiteinhalerx.com.au
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
214.66 мян
214.66 мян
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
376.83 мян
376.83 мян
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
182.51 мян
182.51 мян
-
-
Operating expense
559.06 мян
559.06 мян
-
-
Total operating expenses
559.06 мян
559.06 мян
-
-
Operating income
-344.40 мян
-344.40 мян
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-382.22 мян
-382.22 мян
-
-
EBT excluding unusual items
-382.22 мян
-382.22 мян
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-13.90 мян
-13.90 мян
-
-
Net income
-382.22 мян
-382.22 мян
-
-
Net profit margin
-178.06%
-178.06%
-
-
Earnings per share
-
-
-
-
Interest and investment income
2.87 мян
2.87 мян
-
-
Interest expense
-40.69 мян
-40.69 мян
-
-
Net interest expenses
-37.82 мян
-37.82 мян
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс